Sidney A. Cohen, MD, PhD

Original Contribution

Utility of Sirolimus-Eluting Cypher‚Ñ¢ Stents to Reduce 12-Month
Target Vessel Revascularization in Saphenous Vein Graft Stenoses

08/01/2008

Dean J. Kereiakes , MD, FACC, FSCAI;

Stephen G. Ellis , MD;

David E. Kandzari , MD;

Ken Huber , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Frederic S. Resnic , MD, MSc;

Steven J. Yakubov , MD;

Keith Callahan , MPH;

Marilyn Borgman , RN;

Sidney A. Cohen , MD, PhD;

Approximately 1 million patients are now treated annually in the United States with drug-eluting stents (DES). Usage of these stents is substantiated in many patient and lesion subsets by their documented relative safety and reduction in...

Approximately 1 million patients...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Two-Year Intravascular Ultrasound Observations in Diabetic Patients Treated with Single and Double Dose Sirolimus-Eluting Stents

09/10/2008

J. Eduardo Sousa , MD, PhD;

Junya Ako , MD, PhD;

Ichizo Tsujino , MD, PhD;

Ali H.M. Hassan , MD;

Yoshihisa Shimada , MD, PhD;

Yasuhiro Honda , MD;

Peter J. Fitzgerald , MD, PhD;

Alexandre Antonio Cunha Abizaid , MD, PhD;

Seung-Ho Hur , MD, PhD;

Giulio Guagliumi , MD;

Avinoam Shiran , MD;

Sidney A. Cohen , MD, PhD;

Basil S. Lewis , MD;

ABSTRACT: Background. Diabetes has been reported as an independent predictor of restenosis after drug-eluting stent implantation. The purpose of this study was to assess the long-term impact of increased drug dose in sirolimus-eluting stents...

ABSTRACT: Background. Diabetes...

09/10/2008

Journal of Invasive Cardiology

Original Contribution

Outcomes of Unselected Recipients of Sirolimus-Eluting Stents: The Cypher¬Æ Stent U.S. Post-Marketing Surveillance Registry

02/02/2010

Peter C. Block , MD;

Hiram G. Bezerra , MD, PhD;

Emerson C. Perin , MD, PhD;

Marco A. Costa , MD, PhD;

Gary L. Schaer , MD, FACC, FSCAI;

Stanley Katz , MD, FACC;

Peter B. Berger , MD;

Eric J. Dippel , MD;

Stephen R. Ramee , MD;

Sidney A. Cohen , MD, PhD;

Mirle A. Kellett , MD;

Suzanne Britto , RN;

ABSTRACT: Objective. To examine the 1-year safety and clinical outcomes associated with the post-marketing early unselected use of sirolimus-eluting stents (SES) in the United States. Background. The safety and effectiveness of SES has been...

ABSTRACT: Objective. To examine...

02/02/2010

Journal of Invasive Cardiology